A Breathalyzer for Disease

Our Mission: To save 100,000 lives and $1.5B in healthcare costs.

Our Vision: The global leader in Breath Biopsy® for early detection and precision medicine.

Discover Breath Biopsy

Why Breath?

Uses of Breath Biomarkers

Uses of Breath Biomarkers

Research Products and Services

Research Products and Services

Breath Biopsy VOC Atlas®

Breath Biopsy VOC Atlas®

Investors

About Owlstone Medical

Owlstone Medical is at the forefront of breath biomarker research and development, leading to non-invasive diagnostic tests that can improve early disease detection and precision medicine across different fields including cancer, respiratory, gastrointestinal, the microbiome and liver disease. We offer Breath Biopsy research products and services that enable the comprehensive and reliable analysis of volatile organic compounds from a range of sample types from in vitro cell culture to human breath.

Our Latest Updates

Publication

Owlstone Publishes New VOC Atlas Paper

Owlstone Publishes New VOC Atlas Paper

“Optimized breath analysis: customized analytical methods and enhanced workflow for broader detection of VOCs”

View the Paper

News

Owlstone Medical Enters into a Research Collaboration Agreement with the FDA

Owlstone Medical Enters into a Research Collaboration Agreement with the FDA

The collaboration will develop analytical methods to improve the identification of specific chemicals in complex gaseous mixtures.

Read the press release

News

Owlstone Medical Announces $27 Million USD Investment

Owlstone Medical Announces $27 Million USD Investment

Led by Ventura Capital, funding will be used to accelerate work on lung cancer, liver disease, and digestive disease.

Read the press release

Conference

Breath Biopsy Conference 2025

Breath Biopsy Conference 2025

Join us online on the 5th November 2025 to hear from breath experts from around the world.

Register

Some of Our Customers

Latest insights from the Breath Biopsy Conference